Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

CHEMVET DK A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   0.6% 0.5% 0.6% 0.8% 0.9% 0.8% 8.1% 8.1%   Credit score (0-100)   97 99 96 91 90 89 30 30   Credit rating   AA AA AA AA A A BB BB   Credit limit (kDKK)   1,840.5 2,367.8 2,997.3 3,461.7 2,602.1 3,040.7 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   15,675 19,083 20,565 26,095 24,654 25,502 0.0 0.0   EBITDA   9,792 10,755 13,447 20,029 18,074 18,644 0.0 0.0   EBIT   9,493 10,465 13,158 19,311 17,368 17,978 0.0 0.0   Pre-tax profit (PTP)   9,412.5 10,446.2 13,093.0 19,121.4 17,227.2 18,102.3 0.0 0.0   Net earnings   7,331.9 8,136.7 10,204.3 14,907.9 13,432.4 14,111.8 0.0 0.0   Pre-tax profit without non-rec. items   9,412 10,446 13,093 19,121 17,227 18,102 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   6,617 7,104 7,174 7,761 7,145 6,595 0.0 0.0   Shareholders equity total   11,201 13,338 17,542 20,450 19,882 20,994 6,494 6,494   Interest-bearing liabilities   4,685 4,311 3,967 5,292 3,232 4,769 0.0 0.0   Balance sheet total (assets)   21,803 26,878 30,577 34,426 29,669 32,307 6,494 6,494   Net Debt   3,180 -577 -4,754 -9,441 -1,492 -4,282 -6,494 -6,494     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   15,675 19,083 20,565 26,095 24,654 25,502 0.0 0.0   Gross profit growth   16.4% 21.7% 7.8% 26.9% -5.5% 3.4% -100.0% 0.0%   Employees   11 12 12 11 12 11 0 0   Employee growth %   0.0% 9.1% 0.0% -8.3% 9.1% -8.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   21,803 26,878 30,577 34,426 29,669 32,307 6,494 6,494   Balance sheet change%   1.3% 23.3% 13.8% 12.6% -13.8% 8.9% -79.9% 0.0%   Added value   9,792.4 10,755.4 13,447.2 20,029.4 18,086.5 18,644.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -239 196 -219 -132 -1,322 -1,216 -6,595 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   60.6% 54.8% 64.0% 74.0% 70.4% 70.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   44.4% 43.7% 46.3% 59.4% 54.2% 58.6% 0.0% 0.0%   ROI %   61.3% 62.9% 66.5% 80.1% 70.1% 73.2% 0.0% 0.0%   ROE %   73.1% 66.3% 66.1% 78.5% 66.6% 69.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   51.4% 49.6% 57.4% 59.4% 67.0% 65.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   32.5% -5.4% -35.4% -47.1% -8.3% -23.0% 0.0% 0.0%   Gearing %   41.8% 32.3% 22.6% 25.9% 16.3% 22.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.8% 4.5% 4.8% 3.9% 3.0% 1.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.9 1.6 2.0 1.9 2.4 2.2 0.0 0.0   Current Ratio   2.5 2.1 2.7 2.5 3.4 3.0 0.0 0.0   Cash and cash equivalent   1,505.0 4,888.1 8,720.9 14,732.8 4,723.7 9,050.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   9,034.5 10,397.0 14,585.4 16,187.4 15,875.8 17,138.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   890 896 1,121 1,821 1,507 1,695 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   890 896 1,121 1,821 1,506 1,695 0 0   EBIT / employee   863 872 1,096 1,756 1,447 1,634 0 0   Net earnings / employee   667 678 850 1,355 1,119 1,283 0 0